ducovest

SCHC:ARCA-Schwab International Small-Cap Equity

ETF | Foreign Small/Mid Blend | NYSE Arca

Last Closing

USD 31.03

Change

+0.22 (+0.71)%

Market Cap

USD 0.84B

Volume

0.23M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

The investment seeks to track as closely as possible, before fees and expenses, the total return of FTSE Developed Small Cap ex US Liquid Index. The fund invests at least 90% of its net assets in these stocks, including depositary receipts representing securities of the index; such depository receipts may be in the form of American Depositary receipts, Global Depositary receipts and European Depositary receipts. The index is comprised of small capitalization companies in developed countries outside the United States.

Company Website : www.csimfunds.com.

Currency: USD

Country : USA

Inception Date: 14/01/2010

Primary Benchmark: FTSE Dvlp Small Cap Ex US Liquid NR USD

Primary Index: MSCI ACWI Ex USA NR USD

Gross Expense Ratio: 0.17%

Management Expense Ratio: 0.12 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Symbol Company Name Allocation
HAEK:F Haemato AG 0.47 %
DM Desktop Metal Inc 0.38 %
Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-01-18 )

Largest Industry Peers for Foreign Small/Mid Blend

Symbol Name Mer Price(Change) Market Cap
VSS Vanguard FTSE All-World ex-US .. 0.12 %

-0.06 (-0.05%)

 USD 8.25B
FNDC Schwab Fundamental Internation.. 0.39 %

-0.20 (-0.58%)

 USD 3.17B
GWX SPDR® S&P International Small.. 0.40 %

-0.14 (-0.45%)

 USD 0.64B
ISCF iShares MSCI Intl Small-Cap Mu.. 0.40 %

-0.14 (-0.45%)

 USD 0.54B
HSCZ iShares Currency Hedged MSCI E.. 0.03 %

-0.25 (-0.79%)

 USD 0.12B

ETFs Containing SCHC

N/A

Market Performance

  Market Performance vs. Industry/Classification (Foreign Small/Mid Blend) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.63% 43% F 49% F
Dividend Return N/A N/A N/A N/A F
Total Return 6.63% 43% F 49% F
Trailing 12 Months  
Capital Gain -18.64% 67% D+ 25% F
Dividend Return N/A N/A N/A N/A F
Total Return -18.64% 50% F 22% F
Trailing 5 Years  
Capital Gain -3.48% 75% C 43% F
Dividend Return 9.35% 75% C 31% F
Total Return 5.86% 50% F 35% F
Average Annual (5 Year Horizon)  
Capital Gain 2.93% 50% F 59% D-
Dividend Return 5.29% 33% F 51% F
Total Return 2.36% 83% B 47% F
Risk Return Profile  
Volatility (Standard Deviation) 12.01% 83% B 60% D-
Risk Adjusted Return 44.05% 50% F 53% F
Market Capitalization 0.84B 83% B 67% D+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.